AstraZeneca Pharma India gets DCGI nod to market cancer drug in India

New Delhi: Drug firm AstraZeneca Pharma India today said it has received permission from the Drug Controller General of India (DCGI) to import and market olaparib tablets used for the treatment of ovarian and breast cancer. The permission from the DCGI is for olaparib (Lynparza) tablets in the strengths of 100 mg and 150 mg, AstraZeneca Pharma India said in a BSE filing.

The tablets are a patented product of the AstraZeneca group, it added.

“The import and market permission for olaparib is a significant milestone for women in India living with platinum-sensitive relapsed ovarian cancer and BRCA-mutated HER-2 negative metastatic breast cancer, which has historically been difficulty-to-treat diseases,” AstraZeneca Pharma India MD Gagan Singh said.

Shares of AstraZeneca Pharma India today closed at Rs 1,710.30 per scrip on BSE, up 1.59 per cent from their previous close.

  • Related Posts

    • Pharma
    • July 3, 2025
    • 93 views
    Cipla in talks to add new customers for its China factory, executive says

    SHANGHAI – Indian drugmaker Cipla (CIPL.NS), opens new tab is looking to add at least two new overseas markets for its products manufactured in China, as the firm seeks to…

    • Pharma
    • July 3, 2025
    • 79 views
    No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

    ​Union Minister of Health and Family Welfare said that extensive studies by the Indian Council of Medical Research (ICMR) and All India Institute of Medical Sciences have conclusively established no…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Cipla in talks to add new customers for its China factory, executive says

    Cipla in talks to add new customers for its China factory, executive says

    No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

    No link between COVID-19 vaccines & sudden deaths: ICMR-AIIMS Study

    Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

    Delhi High Court asks DGCI to decide on plea against licensing of weight-loss drugs

    Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs

    Microplastics found in brain, ovaries, and placenta: Experts warn of silent threat to vital organs